Michael G Oefelein

Summary

Affiliation: Case Western Reserve University
Country: USA

Publications

  1. ncbi Association of tobacco use with hormone refractory disease and survival of patients with prostate cancer
    Michael G Oefelein
    Department of Urology, Case Western University School of Medicine, University Hospitals of Cleveland, Cleveland, Ohio 44106, USA
    J Urol 171:2281-4. 2004
  2. ncbi Urologic manifestations of nonurologic diseases gastrointestinal disorders
    Michael G Oefelein
    Case Western Reserve University, School of Medicine, University Urologists of Cleveland, 11100 Euclid Avenue, Cleveland, OH 44106, USA
    Urol Clin North Am 30:63-72. 2003
  3. ncbi The impact of osteoporosis in men treated for prostate cancer
    Michael G Oefelein
    Department of Urology, Case Western Reserve University School of Medicine, University Hospitals of Cleveland, 11100 Euclid Avenue, Cleveland, OH 44106, USA
    Urol Clin North Am 31:313-9. 2004
  4. ncbi Survival of patients with hormone refractory prostate cancer in the prostate specific antigen era
    Michael G Oefelein
    Department of Urology, Case Western Reserve University School of Medicine, University Hospitals of Cleveland, Cleveland, Ohio 44106, USA
    J Urol 171:1525-8. 2004
  5. ncbi Skeletal fractures negatively correlate with overall survival in men with prostate cancer
    Michael G Oefelein
    Department of Urology, University Hospitals of Cleveland, Case Western Reserve School of Medicine, Cleveland, Ohio, USA
    J Urol 168:1005-7. 2002
  6. ncbi Health related quality of life using serum testosterone as the trigger to re-dose long acting depot luteinizing hormone-releasing hormone agonists in patients with prostate cancer
    Michael G Oefelein
    Department of Urology, University Hospitals of Cleveland, Cleveland, Ohio, USA
    J Urol 169:251-5. 2003
  7. ncbi Prognostic significance of obstructive uropathy in advanced prostate cancer
    Michael G Oefelein
    Department of Urology, Case Western University School of Medicine, University Hospitals of Cleveland, Cleveland, Ohio 44106, USA
    Urology 63:1117-21. 2004
  8. ncbi Effective testosterone suppression for patients with prostate cancer: is there a best castration?
    Michael G Oefelein
    Department of Urology, Case Western Reserve University, University Hospitals of Cleveland, Cleveland, Ohio 44106, USA
    Urology 62:207-13. 2003
  9. ncbi Clinical predictors of androgen-independent prostate cancer and survival in the prostate-specific antigen era
    Michael G Oefelein
    Department of Urology, Case Western Reserve University School of Medicine, University Hospitals of Cleveland, Cleveland, Ohio 44106, USA
    Urology 60:120-4. 2002
  10. ncbi Testosterone replacement therapy after primary treatment for prostate cancer
    Piyush K Agarwal
    Department of Urology, Case Western Reserve University School of Medicine and University Hospitals of Cleveland, Cleveland, Ohio 44106, USA
    J Urol 173:533-6. 2005

Collaborators

  • A D Seftel
  • Michael B Chancellor
  • Piyush K Agarwal
  • Robert E Gerstenbluth
  • Sandip Vasavada
  • Martin I Resnick
  • Nehemia Hampel

Detail Information

Publications13

  1. ncbi Association of tobacco use with hormone refractory disease and survival of patients with prostate cancer
    Michael G Oefelein
    Department of Urology, Case Western University School of Medicine, University Hospitals of Cleveland, Cleveland, Ohio 44106, USA
    J Urol 171:2281-4. 2004
    ..We identified time to the development of hormone refractory prostate cancer (HRPC) and survival in men with advanced prostate cancer and examined any association with cigarette smoking history...
  2. ncbi Urologic manifestations of nonurologic diseases gastrointestinal disorders
    Michael G Oefelein
    Case Western Reserve University, School of Medicine, University Urologists of Cleveland, 11100 Euclid Avenue, Cleveland, OH 44106, USA
    Urol Clin North Am 30:63-72. 2003
    ..In general, knowledge of these associated disease processes permit rapid and accurate diagnosis and treatment. The underlying thread is the recognition of one pathophysiological process to explain patterns of a single disease...
  3. ncbi The impact of osteoporosis in men treated for prostate cancer
    Michael G Oefelein
    Department of Urology, Case Western Reserve University School of Medicine, University Hospitals of Cleveland, 11100 Euclid Avenue, Cleveland, OH 44106, USA
    Urol Clin North Am 31:313-9. 2004
    ....
  4. ncbi Survival of patients with hormone refractory prostate cancer in the prostate specific antigen era
    Michael G Oefelein
    Department of Urology, Case Western Reserve University School of Medicine, University Hospitals of Cleveland, Cleveland, Ohio 44106, USA
    J Urol 171:1525-8. 2004
    ..For this reason we studied overall survival and the clinical variables that influence survival in patients with hormone refractory prostate cancer...
  5. ncbi Skeletal fractures negatively correlate with overall survival in men with prostate cancer
    Michael G Oefelein
    Department of Urology, University Hospitals of Cleveland, Case Western Reserve School of Medicine, Cleveland, Ohio, USA
    J Urol 168:1005-7. 2002
    ..We assessed the correlation of skeletal fracture with survival in men with prostate cancer on chronic androgen suppressive therapy...
  6. ncbi Health related quality of life using serum testosterone as the trigger to re-dose long acting depot luteinizing hormone-releasing hormone agonists in patients with prostate cancer
    Michael G Oefelein
    Department of Urology, University Hospitals of Cleveland, Cleveland, Ohio, USA
    J Urol 169:251-5. 2003
    ....
  7. ncbi Prognostic significance of obstructive uropathy in advanced prostate cancer
    Michael G Oefelein
    Department of Urology, Case Western University School of Medicine, University Hospitals of Cleveland, Cleveland, Ohio 44106, USA
    Urology 63:1117-21. 2004
    ....
  8. ncbi Effective testosterone suppression for patients with prostate cancer: is there a best castration?
    Michael G Oefelein
    Department of Urology, Case Western Reserve University, University Hospitals of Cleveland, Cleveland, Ohio 44106, USA
    Urology 62:207-13. 2003
  9. ncbi Clinical predictors of androgen-independent prostate cancer and survival in the prostate-specific antigen era
    Michael G Oefelein
    Department of Urology, Case Western Reserve University School of Medicine, University Hospitals of Cleveland, Cleveland, Ohio 44106, USA
    Urology 60:120-4. 2002
    ..To further characterize and identify novel predictors of androgen-independent prostate cancer (AIPC) and survival in the prostate-specific antigen (PSA) era...
  10. ncbi Testosterone replacement therapy after primary treatment for prostate cancer
    Piyush K Agarwal
    Department of Urology, Case Western Reserve University School of Medicine and University Hospitals of Cleveland, Cleveland, Ohio 44106, USA
    J Urol 173:533-6. 2005
    ....
  11. ncbi The accuracy of the increased prostate specific antigen level (greater than or equal to 20 ng./ml.) in predicting prostate cancer: is biopsy always required?
    Robert E Gerstenbluth
    Cleveland Veterans Affairs Medical Center, Case Western Reserve University School of Medicine, Ohio, USA
    J Urol 168:1990-3. 2002
    ..We examined a data base of men undergoing prostate biopsy to determine the accuracy of high PSA levels (greater than or equal to 20 ng./ml.) in predicting prostate cancer...
  12. doi Obesity is associated with a more severe overactive bladder disease state that is effectively treated with once-daily administration of trospium chloride extended release
    Michael B Chancellor
    Department of Urology, William Beaumont Hospital, Detroit, Michigan, USA
    Neurourol Urodyn 29:551-4. 2010
    ..The goal of this study is to examine the efficacy of once daily trospium chloride (Sanctura) XR in overweight and obese patients with the overactive bladder syndrome...
  13. ncbi Prospective predictors of urinary continence after anatomical radical retropubic prostatectomy: a multivariate analysis
    Michael G Oefelein
    Case Western Reserve University, Department of Urology, University Hospitals of Cleveland, 11100 Euclid Avenue, Cleveland, Ohio 44106, USA
    World J Urol 22:267-71. 2004
    ..05) prolonged time to achieve pad-free urinary continence. In conclusion, prostate size and surgical technique were the most useful variables in predicting time to pad-free urinary continence after ARP...